News

Check category
/
/
China has broken the monopoly of foreign patent drugs in the fields of lung cancer and leukemia, and the new drug creation specializes in "bumper harvest"

China has broken the monopoly of foreign patent drugs in the fields of lung cancer and leukemia, and the new drug creation specializes in "bumper harvest"

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2019-06-18 17:40
  • Views:

(Summary description)Lung cancer, leukemia and other fields have broken foreign monopoly. The domestic small molecule targeted drug market has promoted the price reduction of foreign drugs in China by more than 50%...

China has broken the monopoly of foreign patent drugs in the fields of lung cancer and leukemia, and the new drug creation specializes in "bumper harvest"

(Summary description)Lung cancer, leukemia and other fields have broken foreign monopoly. The domestic small molecule targeted drug market has promoted the price reduction of foreign drugs in China by more than 50%...

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2019-06-18 17:40
  • Views:
Information

Lung cancer, leukemia and other fields have broken foreign monopoly. The domestic small molecule targeted drug market has promoted the price reduction of foreign drugs in China by more than 50%... The national science and technology major special achievements not only have the "hard technology" of 4G mobile communication and Beidou satellite navigation. There are biotechnology innovations that are closely related to the health of the people.

 

On the 22nd, the reporter learned at the press conference of the "New Drug Creation National Science and Technology Major Project" held by the Ministry of Science and Technology that China has broken the monopoly of foreign drugs in the fields of lung cancer, leukemia and drug-resistant bacteria, and the research and development innovation capability and industrial development of the bio-pharmaceutical industry continued. Enhance, achieve stage results, and fruitful results.

 

The drug problem has a bearing on the lives and health of the people. It has been a painful lesson in the world. Non-clinical evaluation is an important part of the necessary stage of new drug research and development. Sang Guowei, the chief technical officer of the new drug creation and academician of the Chinese Academy of Engineering, said that with the special support of new drug creation, China's drug non-clinical evaluation platform has achieved a series of major breakthroughs. The pre-clinical evaluation of new drugs has been in line with international standards. The key technologies have reached the international advanced level, which has strongly supported the research and development of new drugs in China and ensured the use of drugs by the public.

Scan the QR code to read on your phone

Previous: None
Next: None
Previous: None
Next: None

Copyright 2019 ©sdhopepharm.com All Rights Reserved       浙ICP备10036259号

Power by:300.cn

Copyright 2019 ©sdhopepharm.comnehe.com 

浙ICP备10036259号

Power by: 300.cn